1. Home
  2. GP vs NERV Comparison

GP vs NERV Comparison

Compare GP & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GP
  • NERV
  • Stock Information
  • Founded
  • GP 2010
  • NERV 2007
  • Country
  • GP Canada
  • NERV United States
  • Employees
  • GP N/A
  • NERV N/A
  • Industry
  • GP Construction/Ag Equipment/Trucks
  • NERV Biotechnology: Pharmaceutical Preparations
  • Sector
  • GP Consumer Discretionary
  • NERV Health Care
  • Exchange
  • GP Nasdaq
  • NERV Nasdaq
  • Market Cap
  • GP 12.7M
  • NERV 12.0M
  • IPO Year
  • GP 2020
  • NERV 2014
  • Fundamental
  • Price
  • GP $0.43
  • NERV $1.68
  • Analyst Decision
  • GP Strong Buy
  • NERV Hold
  • Analyst Count
  • GP 2
  • NERV 1
  • Target Price
  • GP $2.33
  • NERV $5.00
  • AVG Volume (30 Days)
  • GP 84.8K
  • NERV 5.8K
  • Earning Date
  • GP 08-13-2025
  • NERV 08-05-2025
  • Dividend Yield
  • GP N/A
  • NERV N/A
  • EPS Growth
  • GP N/A
  • NERV N/A
  • EPS
  • GP N/A
  • NERV 0.83
  • Revenue
  • GP $20,656,035.00
  • NERV N/A
  • Revenue This Year
  • GP N/A
  • NERV N/A
  • Revenue Next Year
  • GP $94.25
  • NERV N/A
  • P/E Ratio
  • GP N/A
  • NERV $2.05
  • Revenue Growth
  • GP N/A
  • NERV N/A
  • 52 Week Low
  • GP $0.36
  • NERV $1.15
  • 52 Week High
  • GP $1.90
  • NERV $3.50
  • Technical
  • Relative Strength Index (RSI)
  • GP 55.17
  • NERV 47.97
  • Support Level
  • GP $0.38
  • NERV $1.59
  • Resistance Level
  • GP $0.43
  • NERV $1.75
  • Average True Range (ATR)
  • GP 0.03
  • NERV 0.09
  • MACD
  • GP 0.01
  • NERV -0.02
  • Stochastic Oscillator
  • GP 79.08
  • NERV 36.19

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: